Urinary mRNA markers of epithelial-mesenchymal transition correlate with progression of diabetic nephropathy

Clinical Endocrinology

Volumn 76, Issue 5, 2012, Pages 657-664

  Zheng, Min ^a   Lv, Lin Li ^a   Cao, Yu Han ^a   Zhang, Jian Dong ^a   Wu, Min ^a   Ma, Kun Ling ^a   Phillips, Aled O ^b   Liu, Bi Cheng ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; CREATININE; FIBRONECTIN; GELATINASE B; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MALE; NON INVASIVE PROCEDURE; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; SEDIMENT; URINALYSIS; URINARY EXCRETION;

ACTINS; ADULT; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FIBRONECTINS; GENE EXPRESSION; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MUSCLE, SMOOTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84859627330     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04192.x     Document Type: Article

References (36)

1. Dagogo-Jack, S. (2006) Primary prevention of type-2 diabetes in developing countries. Journal of the National Medical Association, 98, 415-419.
2. Cooper, M.E., Jandeleit-Dahm, K. & Thomas, M.C. (2005) Targets to retard the progression of diabetic nephropathy. Kidney International, 68, 1439-1445. (Pubitemid 43169889)
3. Yang, J. & Liu, Y. (2001) Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. American Journal of Pathology, 159, 1465-1475. (Pubitemid 32947976)
4. Liu, Y. (2010) New insights into epithelial-mesenchymal transition in kidney fibrosis. Journal of the American Society of Nephrology, 21, 212-222.
5. Kalluri, R. & Weinberg, R.A. (2009) The basics of epithelial-mesenchymal transition. Journal of Clinical Investigation, 119, 1420-1428.
6. Guarino, M., Tosoni, A. & Nebuloni, M. (2009) Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition. Human Pathology, 40, 1365-1376.
7. Li, Q., Liu, B.C., Lv, L.L. et al. (2011) Monocytes induce proximal tubular epithelial mesenchymal transition through NF-kappa B dependent upregulation of ICAM-1. Journal of Cellular Biochemistry, 112, 1585-1592.
8. Burns, W.C., Twigg, S.M., Forbes, J.M. et al. (2006) Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. Journal of the American Society of Nephrology, 17, 2484-2494. (Pubitemid 44300964)
9. Li, J., Qu, X. & Bertram, J.F. (2009) Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. American Journal of Pathology, 175, 1380-1388.
10. Yamaguchi, Y., Iwano, M., Suzuki, D. et al. (2009) Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. American Journal of Kidney Diseases, 54, 653-664.
11. Hanke, M., Kausch, I., Dahmen, G. et al. (2007) Detailed technical analysis of urine RNA-based tumor diagnostics reveals ETS2/urokinase plasminogen activator to be a novel marker for bladder cancer. Clinical Chemistry, 53, 2070-2077. (Pubitemid 350197289)
12. Li, B., Hartono, C., Ding, R. et al. (2001) Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. New England Journal of Medicine, 344, 947-954. (Pubitemid 32240312)
13. Muthukumar, T., Dadhania, D., Ding, R. et al. (2005) Messenger RNA for FOXP3 in the urine of renal-allograft recipients. New England Journal of Medicine, 353, 2342-2351. (Pubitemid 41713746)
14. Chan, R.W., Lai, F.M., Li, E.K. et al. (2007) Expression of T-bet, a type 1 T-helper cell transcription factor, in the urinary sediment of lupus patients predicts disease flare. Rheumatology (Oxford), 46, 44-48. (Pubitemid 44932782)
15. Gomez-Alamillo, C., Benito-Hernandez, A., Ramos-Barron, M.A. et al. (2010) Analysis of urinary gene expression of epithelial-mesenchymal transition markers in kidney transplant recipients. Transplantation Proceedings, 42, 2886-2888.
16. (2007) KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. American Journal of Kidney Diseases, 49, S12-S154.
17. Ma, Y.C., Zuo, L., Chen, J.H. et al. (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. Journal of the American Society of Nephrology, 17, 2937-2944. (Pubitemid 44484685)
18. Li, M.X. & Liu, B.C. (2007) Epithelial to mesenchymal transition in the progression of tubulointerstitial fibrosis. Chinese Medical Journal, 120, 1925-1930.
19. Iwano, M., Plieth, D., Danoff, T.M. et al. (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. Journal of Clinical Investigation, 110, 341-350. (Pubitemid 34847966)
20. Simonson, M.S. (2007) Phenotypic transitions and fibrosis in diabetic nephropathy. Kidney International, 71, 846-854.
21. Li, Y., Kang, Y.S., Dai, C. et al. (2008) Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. American Journal of Pathology, 172, 299-308. (Pubitemid 351282018)
22. Humphreys, B.D., Lin, S.L., Kobayashi, A. et al. (2010) Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. American Journal of Pathology, 176, 85-97.
23. Dai, H.Y., Zheng, M., Tang, R.N. et al. (2011) Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy. American Journal of the Medical Sciences, 341, 207-214.
24. Kimura, J., Ichii, O., Otsuka, S. et al. (2011) Quantitative and qualitative urinary cellular patterns correlate with progression of murine glomerulonephritis. PLoS ONE, 6, e16472.
25. Wang, G., Kwan, B.C., Lai, F.M. et al. (2008) Expression of microRNAs in the urinary sediment of patients with IgA nephropathy. Disease Markers, 28, 79-86.
26. Navarro-Munoz, M., Ibernon, M., Perez, V. et al. (2011) Messenger RNA expression of B7-1 and NPHS1 in urinary sediment could be useful to differentiate between minimal change disease and focal segmental glomerulosclerosis in adult patients. Nephrology Dialysis Transplantation, 26, 3914-3923.
27. Zheng, M., Lv, L.L., Ni, J. et al. (2011) Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy. PLoS ONE, 6, e20431.
28. Zeisberg, M. & Neilson, E.G. (2009) Biomarkers for epithelial-mesenchymal transitions. Journal of Clinical Investigation, 119, 1429-1437.
29. Tan, T.K., Zheng, G., Hsu, T.T. et al. (2010) Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells. American Journal of Pathology, 176, 1256-1270.
30. Liu, B.C., Zhang, L., Lv, L.L. et al. (2006) Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease. American Journal of Nephrology, 26, 483-490. (Pubitemid 44971740)
31. Rastaldi, M.P., Ferrario, F., Giardino, L. et al. (2002) Epithelialmesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney International, 62, 137-146. (Pubitemid 34754056)
32. Vongwiwatana, A., Tasanarong, A., Rayner, D.C. et al. (2005) Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. American Journal of Transplantation, 5, 1367-1374. (Pubitemid 40839427)
33. Strutz, F.M. (2009) EMT and proteinuria as progression factors. Kidney International, 75, 475-481.
34. Djamali, A., Reese, S., Yracheta, J. et al. (2005) Epithelial-to- mesenchymal transition and oxidative stress in chronic allograft nephropathy. American Journal of Transplantation, 5, 500-509. (Pubitemid 40313341)
35. Ichikawa, I., Ma, J., Motojima, M. et al. (2005) Podocyte damage damages podocytes: autonomous vicious cycle that drives local spread of glomerular sclerosis. Current Opinion in Nephrology and Hypertension, 14, 205-210. (Pubitemid 40685630)
36. Burns, W.C. & Thomas, M.C. (2010) The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology. Expert Reviews in Molecular Medicine, 12, e17.